Dianthus Therapeutics (DNTH) Q4 2023 Earnings

21MarConfirmed
Q4 2022
Q1 2023
Q3 2023
Q4 2023
-7.7
-5.37
-3.04
-0.71

Details

Expected EPS
-0.94
Actual EPS
-0.71
Surprise EPS
0.23
Surprise Percent
+24.47%

Description

Dianthus Therapeutics (DNTH) has reported earnings of -0.71 per share for Q4 2023.

0 Comments

Share your thoughts